Company news
Intensity Therapeutics, Inc. news in 2023
Intensity Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer
December 11, 2023
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS
December 7, 2023
Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
November 30, 2023
Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
November 12, 2023
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023
November 1, 2023
Intensity Therapeutics Receives Orphan Drug Designation for the three key ingredients in INT230-6 for the Treatment of Soft Tissue Sarcoma
September 6, 2023
Intensity Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 4, 2023
Intensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
August 13, 2023
Intensity Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update
August 6, 2023
Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds
July 9, 2023
Intensity Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds
June 28, 2023
Intensity Therapeutics Reports INT230-6 Can Cause Immune Priming in Historically Quiescent Breast Cancers
June 5, 2023
Intensity Therapeutics' INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas
June 2, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (September 2023)
Investor deck · 22 slides · Sep 5, 2023
- IPO Roadshow (June 2023)
IPO roadshow · 33 slides · Jun 23, 2023
- IPO Roadshow (January 2023)
IPO roadshow · 27 slides · Jan 13, 2023